Affordable Access

Publisher Website

Mitotic and in situ end-labeling apoptotic indices as prognostic markers in malignant mesothelioma

Authors
Journal
Annals of Diagnostic Pathology
1092-9134
Publisher
Elsevier
Publication Date
Volume
4
Issue
3
Identifiers
DOI: 10.1016/s1092-9134(00)90036-4
Disciplines
  • Medicine

Abstract

Abstract The prognostic role of mitotic and apoptotic indices in 60 patients with malignant mesothelioma was examined on hematoxylin-eosin-stained sections. The findings were compared with apoptotic indices determined by in situ end labeling (ISEL) in 35 of the cases. There was a significant survival advantage associated with lower mitotic counts and a lower apoptotic index defined by ISEL ( P < .05). There was no association between the apoptotic index derived from the hematoxylin-eosinstained sections and prognosis (P = .90). However, there was a positive association between the apoptotic counts calculated from hematoxylin-eosin- and ISEL-stained sections ( P < .01). The mitotic count and ISEL apoptotic index are potentially useful markers of prognosis in malignant mesothelioma.

There are no comments yet on this publication. Be the first to share your thoughts.